The global market analysis of 4 Factor Pro-thrombin Complex Concentrate includes revenue forecasts, key manufacturers like Prothya Biosolutions and Takeda, and regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The plasma fractionation industry is projected to reach $40.4 billion by 2028, driven by biotechnological advancements and increasing demand for plasma-derived therapies. Prothya Biosolutions, formed in 2021 through a merger, specializes in blood plasma collection and production of medicinal products.

Plasma Industry Market Insights